Penserra Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1K | Hold |
12
| – | – | ﹤0.01% | 976 |
|
|
2025
Q1 | $1K | Sell |
12
-370
| -97% | -$30.8K | ﹤0.01% | 1005 |
|
|
2024
Q4 | $57K | Buy |
382
+370
| +3,083% | +$55.2K | ﹤0.01% | 918 |
|
|
2024
Q3 | $2K | Hold |
12
| – | – | ﹤0.01% | 1007 |
|
|
2024
Q2 | $3K | Hold |
12
| – | – | ﹤0.01% | 1100 |
|
|
2024
Q1 | $2K | Sell |
12
-659
| -98% | -$110K | ﹤0.01% | 1121 |
|
|
2023
Q4 | $173K | Sell |
671
-189
| -22% | -$48.7K | ﹤0.01% | 783 |
|
|
2023
Q3 | $220K | Sell |
860
-134
| -13% | -$34.3K | ﹤0.01% | 717 |
|
|
2023
Q2 | $282K | Buy |
994
+926
| +1,362% | +$263K | 0.01% | 682 |
|
|
2023
Q1 | $18K | Sell |
68
-10
| -13% | -$2.65K | ﹤0.01% | 897 |
|
|
2022
Q4 | $21K | Sell |
78
-58
| -43% | -$15.6K | ﹤0.01% | 942 |
|
|
2022
Q3 | $36K | Buy |
136
+112
| +467% | +$29.6K | ﹤0.01% | 838 |
|
|
2022
Q2 | $4K | Sell |
24
-8
| -25% | -$1.33K | ﹤0.01% | 1357 |
|
|
2022
Q1 | $6K | Sell |
32
-46
| -59% | -$8.63K | ﹤0.01% | 1430 |
|
|
2021
Q4 | $18K | Buy |
78
+24
| +44% | +$5.54K | ﹤0.01% | 1242 |
|
|
2021
Q3 | $15K | Buy |
54
+4
| +8% | +$1.11K | ﹤0.01% | 1291 |
|
|
2021
Q2 | $17K | Buy |
+50
| New | +$17K | ﹤0.01% | 1181 |
|
|
2016
Q4 | – | Sell |
-589
| Closed | -$184K | – | 920 |
|
|
2016
Q3 | $184K | Buy |
+589
| New | +$184K | 0.02% | 166 |
|
|
2016
Q1 | – | Sell |
-20
| Closed | -$6K | – | 982 |
|
|
2015
Q4 | $6K | Buy |
+20
| New | +$6K | ﹤0.01% | 688 |
|